Ropharma Bras is selling at 0.17 as of the 25th of December 2024; that is 5.56 percent down since the beginning of the trading day. The stock's open price was 0.18. Ropharma Bras has 50 percent odds of going through some form of financial distress in the next two years and did not have a very good performance for investor during the last 90 trading days. The performance scores are derived for the period starting the 5th of January 2023 and ending today, the 25th of December 2024. Click here to learn more.
Although Ropharma Bras' alpha and beta are two of the key measurements used to evaluate Ropharma Bras' performance over the market, the standard measures of volatility play an important role as well.
The output start index for this execution was zero with a total number of output elements of sixty-one. Ropharma Bras Inverse Tangent Over Price Movement function is an inverse trigonometric method to describe Ropharma Bras price patterns.
Our tools can tell you how much better you can do entering a position in Ropharma Bras without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.
Did you try this?
Run Alpha Finder Now
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Ropharma Bras financial ratios help investors to determine whether Ropharma Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ropharma with respect to the benefits of owning Ropharma Bras security.